Following a public comment period, the Federal Trade Commission has approved a final order settling charges that DaVita, Inc.’s acquisition of CDSI I Holding Company, also known as DSI, was anticompetitive and reduced competition in the U.S. market for outpatient dialysis clinics. The final order requires DaVita to sell 29 outpatient dialysis clinics in 22 […]
Tag Archives: Competition
FTC Study Finds that in FY 2011, Pharmaceutical Industry Continued to Make Numerous Business Deals that Delay Consumers Access to Lower-Cost Generic Drugs
According to an overview of industry data released by the staff of the Federal Trade Commission, in Fiscal Year 2011, pharmaceutical companies continued a recent anticompetitive trend of paying potential generic rivals to delay the introduction of lower-cost prescription drug alternatives for American consumers. The FTC staff report found that drug companies entered into 28 […]
FTC Seeks Public Comment on Universal Health Services’ Application to Sell Puerto Rico Assets
Universal Health Services, Inc. has submitted an application to the Federal Trade Commission to sell what are known as the Puerto Rico Divestiture Assets, including Hospital San Juan Capestrano and its affiliated outpatient centers, to Donald R. Dizney and David A. Dizney, through two companies that are members of the United Medical Corporation (UMC). Universal […]
FTC Requires Sale of Generic Cancer Pain Drug and Muscle Relaxant as Conditions of Tevas $6.8 Billion Acquisition of Cephalon
To protect competition in the market for prescription drugs, the Federal Trade Commission will require Teva Pharmaceutical Industries Ltd. to sell the rights and assets related to a generic cancer pain drug and a generic muscle relaxant, as a condition of its proposed $6.8 billion acquisition of rival drug firm Cephalon, Inc. In addition, the […]
FTC Approves Dow Chemical Company’s Application to Amend Asset Purchase Agreement with Arkema Inc.
Following a public comment period, the Federal Trade Commission has approved an application by The Dow Chemical Company to amend an asset purchase agreement executed on July 31, 2009, between Dow and Arkema Inc. The application was required by the FTC’s final 2009 order regarding Dow’s acquisition of Rohm & Haas, which requires Dow to […]
FTC Seeks Public Comment on BASFs application to extend manufacturing agreement related to 2009 Acquisition of Ciba
The Federal Trade Commission is seeking public comment on an application by global chemical company BASF SE to extend a manufacturing agreement, entered into in compliance with a 2009 settlement order, which imposed certain requirements on BASF’s acquisition of rival Ciba Holding, Inc. BASF is requesting FTC approval to extend an agreement with Dominion Colour […]
FTC Approves 90-Day Extension for Trustee in Tops Markets Matter to Sell Former Penn Traffic Supermarket in Bath, New York
The Federal Trade Commission has approved a divestiture trustee’s request for a 90-day extension of the deadline for selling a former Penn Traffic supermarket in Bath, New York. Tops Markets is required to divest the Bath store following its acquisition of Penn Traffic last year. Tops is required to divest a total of seven supermarkets […]
Universal Health Services Withdraws Application to Sell Las Vegas Psychiatric Facilities
Universal Health Services, Inc. (UHS) has withdrawn its application seeking Federal Trade Commission approval to sell its Las Vegas psychiatric facilities, including Montevista Hospital and Red Rock Behavioral Health Hospital, to Dr. Soon Kim through Signature Health Services, LLC, which does business as Aurora Behavioral Healthcare. UHS continues to be required to sell the Las […]
FTC Requires Dialysis Services Company DaVita, Inc. to Sell 29 Clinicsto Resolve Anticompetitive Effects of its Proposed Acquisition of DSI
The Federal Trade Commission will require dialysis services company DaVita, Inc. to sell 29 outpatient dialysis clinics around the United States, under a proposed settlement that resolves FTC charges that DaVita’s proposed $689 million acquisition of rival CDSI I Holding Company, Inc., also known as DSI, would be anticompetitive. The proposed settlement preserves competition in […]
FTC Seeks Public Comment on Dow Chemical’s Application to Sell Its Torrance, California, Acrylic Latex Plant Property to Hager Pacific
The Federal Trade Commission is seeking public comment on The Dow Chemical Company’s application for FTC approval to sell to Hager Pacific Acquisitions, LLC, real estate and other property in Torrance, California, which is related to a latex polymers business that Dow previously divested to Arkema Inc. Hager Pacific Acquisitions, LLC is a subsidiary of […]